Skip to search.
 FTSE 100 Down 0.04%

MannKind Corp. (MNKD)

-NasdaqGM
6.52 Down 0.30(4.40%) 27 Feb 21:00
|After Hours: : 6.55 Up 0.03 (0.46%) 28 Feb 00:59
Add to Portfolio
Prev Close:6.82
Open:6.75
Bid:6.50 x 3000
Ask:N/A
1y Target Est:8.66
Beta:2.78
Earnings Date:11 May - 15 May (Est.)
Day's Range:6.50 - 6.77
52wk Range:3.80 - 11.48
Volume:6,449,467
Avg Vol (3m):5,288,450
Market Cap:2.58b
P/E (ttm):N/A
EPS (ttm):-0.58
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MNKDDown 4.40%2.58b
LLYUp 0.20%74.42b
GSKDown 0.88%114.07b
NVOUp 0.46%124.14b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Mar-15) :-0.08
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback